Literature DB >> 28363996

miR-34a and miR-34b/c Suppress Intestinal Tumorigenesis.

Longchang Jiang1, Heiko Hermeking2,3,4.   

Abstract

The p53-inducible miR-34a and miR-34b/c genes are frequently silenced in colorectal cancer. To address the in vivo relevance of miR-34a/b/c function for suppression of intestinal tumor formation, we generated ApcMin/+ mice with deletions of the miR-34a and/or miR-34b/c genes separately or in combination. Combined deletion of miR-34a/b/c increased the number of intestinal stem cells as well as Paneth and Goblet cells, resulting in enlarged intestinal crypts. miR-34a/b/c-deficient ApcMin/+ mice displayed an increased tumor burden and grade and decreased survival. miR-34a/b/c-deficient adenomas showed elevated proliferation and decreased apoptosis and displayed pronounced bacterial infiltration, which may be due to an observed decrease in infiltrating immune cells and downregulation of barrier proteins. mRNA induction in miR-34a/b/c-deficient tumors was enriched for miR-34a/b/c seed-matching sites and for mRNAs encoding proteins related to epithelial-mesenchymal transition, stemness, and Wnt signaling. Accordingly, cells explanted from miR-34a/b/c-deficient adenomas formed tumor organoids at an increased rate. Several upregulated miR-34 targets displayed elevated expression in primary human colorectal cancers that was associated with lymph-node metastases (INHBB, AXL, FGFR1, and PDFGRB) and upregulation of INHBB and AXL in primary colorectal cancer was associated with poor patient survival. In conclusion, our results show that miR-34a/b/c suppress tumor formation caused by loss of Apc and control intestinal stem cell and secretory cell homeostasis by downregulation of multiple target mRNAs. Cancer Res; 77(10); 2746-58. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28363996     DOI: 10.1158/0008-5472.CAN-16-2183

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  33 in total

1.  Association Between Genetic Variant in the Promoter of Pri-miR-34b/c and Risk of Glioma.

Authors:  Jinghui Li; Xiaoyu Liu; Yu Qiao; Renli Qi; Shunjin Liu; Jing Guo; Yang Gui; Juanjuan Li; Hualin Yu
Journal:  Front Oncol       Date:  2018-09-26       Impact factor: 6.244

2.  MicroRNA-106b-5p (miR-106b-5p) suppresses the proliferation and metastasis of cervical cancer cells via down-regulating fibroblast growth factor 4 (FGF4) expression.

Authors:  Lei Hongwei; Li Juan; Xu Xiaoying; Fan Zhijun
Journal:  Cytotechnology       Date:  2022-06-06       Impact factor: 2.040

Review 3.  Mir-34a: a regulatory hub with versatile functions that controls osteosarcoma networks.

Authors:  Zhimin Yang; Tang Liu; Xiaolei Ren; Mei Yang; Chao Tu; Zhihong Li
Journal:  Cell Cycle       Date:  2022-06-14       Impact factor: 5.173

Review 4.  The comprehensive landscape of miR-34a in cancer research.

Authors:  Sijing Li; Xiaohui Wei; Jinyong He; Quanquan Cao; Danyu Du; Xiaoman Zhan; Yuqi Zeng; Shengtao Yuan; Li Sun
Journal:  Cancer Metastasis Rev       Date:  2021-05-06       Impact factor: 9.264

Review 5.  microRNA-based diagnostic and therapeutic applications in cancer medicine.

Authors:  Lorenzo F Sempere; Asfar S Azmi; Anna Moore
Journal:  Wiley Interdiscip Rev RNA       Date:  2021-05-17       Impact factor: 9.957

Review 6.  RNA in cancer.

Authors:  Gregory J Goodall; Vihandha O Wickramasinghe
Journal:  Nat Rev Cancer       Date:  2020-10-20       Impact factor: 60.716

Review 7.  MicroRNAs Are Key Molecules Involved in the Gene Regulation Network of Colorectal Cancer.

Authors:  Fangfang Yang; Guoyun Xuan; Yixin Chen; Lichao Cao; Min Zhao; Chen Wang; Erfei Chen
Journal:  Front Cell Dev Biol       Date:  2022-04-08

8.  MicroRNA‑34a inhibits liver cancer cell growth by reprogramming glucose metabolism.

Authors:  Hai-Feng Zhang; Yi-Cheng Wang; Yi-Di Han
Journal:  Mol Med Rep       Date:  2018-01-09       Impact factor: 2.952

9.  TissGDB: tissue-specific gene database in cancer.

Authors:  Pora Kim; Aekyung Park; Guangchun Han; Hua Sun; Peilin Jia; Zhongming Zhao
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

10.  Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer.

Authors:  Dagui Lin; Wenhua Fan; Rongxin Zhang; Enen Zhao; Pansong Li; Wenhao Zhou; Jianhong Peng; Liren Li
Journal:  J Transl Med       Date:  2021-06-30       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.